Étude de cohorte prospective observationnelle de Suivi de l’utilisation de molécules innovAntes en Cancérologie et en Hématologie pour les enfants, les Adolescents et les jeunes adultes en situation d’échec thérapeutique ou en rechute et non éligibles à un essai clinique (SACHA)
Gustave Roussy clinical research division is relying on a board to implement the clinical research strategy, to coordinate activities, to bring the projects into operation and to supervise the centralized clinical research platform.
Gustave Roussy clinical research is organized to enhance its performance, to develop its ability to manage large national and international academic trials with high added value and to strengthen Gustave Roussy position as a preferred innovative trials platform for pharma companies.
As an Investigator site, Gustave Roussy has a Clinical Operations Unit ensuring clinical research activities for all therapeutic trials and clinical studies. This service is provided regardless of the sponsor category (pharma industries, biotech, scientific associations, academic institutions), at all development phases (from early to advanced phase) including strategic areas such as Molecular Medicine, Antitumor Immunology, DNA repair and rare Cancers.
The liver is a vital organ with many functions. It produces bile, filters blood, stores glucose and produces substances that are essential for maintaining balance within the body.